Skip to Content
Biotechnology

Burger King is going to start selling a meat-free “Impossible Whopper”

The plant-based burger will be available at 57 locations in St. Louis starting today, but it could eventually be available in all the company’s 7,200 US restaurants—and beyond—if the trial is successful.  

What’s it made of? The patty incorporates heme extracted from soy plants’ roots. Heme is a molecule found in every living plant and animal, but most abundantly in animals. The company that created the burger, Impossible Foods, says that “heme is what makes meat taste like meat.”

Health benefits: The burger contains 15% less fat and 90% less cholesterol than a beef Whopper but costs $1 more. It comes with a dollop of mayonnaise, so it is merely vegetarian rather than vegan. The meat-free mix used in the burger is also used for recipes sold at the fast food chain, White Castle.

Mission Impossible: The burger has been developed as part of Impossible Foods’ overall mission to wean us off farmed meat for health, ethical, and environmental reasons. While meat-free patties are increasingly impressive, it’s a lot harder to re-create the experience of eating a steak. That’s the next frontier for Impossible and other meat-substitute startups.

For more about ways in which firms are creating "meat-free" meat read: The race to grow a planet-friendly steak

 

Sign up here to our daily newsletter The Download to get your dose of the latest must-read news from the world of emerging tech.

 

Deep Dive

Biotechnology

The first babies conceived with a sperm-injecting robot have been born

Meet the startups trying to engineer a desktop fertility machine.

Doctors have performed brain surgery on a fetus in one of the first operations of its kind

A baby girl who developed a life-threatening brain condition was successfully treated before she was born—and is now a healthy seven-week-old.

A brain implant changed her life. Then it was removed against her will.

Her case highlights why we need to enshrine neuro rights in law.

The FDA just approved rub-on gene therapy that helps “butterfly” children

Biotech companies are getting creative with how they deliver DNA fixes into people's bodies.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.